MiNK Therapeutics Inc. (INKT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    MiNK Therapeutics Inc.

    NASDAQ: INKT · Real-Time Price · USD
    15.02
    -0.44 (-2.85%)
    At close: Oct 03, 2025, 3:59 PM
    14.50
    -3.43%
    After-hours: Oct 03, 2025, 07:06 PM EDT

    MiNK Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a 2.7B n/a
    Cost of Revenue
    		 215.44K 204.62K 30.95B 77.96K
    Gross Profit
    		 -215.44K -204.62K -28.24B -77.96K
    Operating Income
    		 -10.65M -22.92M -30.95M -28.36M
    Interest Income
    		 172.57K 463.26K 253.32K 2.43K
    Pretax Income
    		 -10.78M -22.46M -27.99M -30.21M
    Net Income
    		 -10.78M -22.46M -27.99M -30.21M
    Selling & General & Admin
    		 4.1M 7.43M 7.83M 4.64M
    Research & Development
    		 6.34M 15.49M 23.12M 13.97M
    Other Expenses
    		 n/a -204.62K n/a 9.75M
    Operating Expenses
    		 10.43M 22.72M 30.95M 28.36M
    Interest Expense
    		 n/a n/a 253.32K 2.43M
    Selling & Marketing Expenses
    		 -4.31B n/a n/a n/a
    Cost & Expenses
    		 10.65M 22.92M 30.95M 28.36M
    Income Tax Expense
    		 n/a n/a -3.21M -7.1M
    Shares Outstanding (Basic)
    		 3.74M 3.44M 3.37M 3.35M
    Shares Outstanding (Diluted)
    		 3.86M 3.44M 3.37M 3.35M
    EPS (Basic)
    		 -2.9 -6.54 -8.31 -9.03
    EPS (Diluted)
    		 -2.8 -6.54 -8.31 -9.03
    EBITDA
    		 -10.57M -22.25M -30.83M -27.7M
    EBIT
    		 -10.78M -22.46M -30.95M -27.78M
    Depreciation & Amortization
    		 215.44K 204.62K 121.75K 77.96K

    Add to Watchlist